Thromb Haemost 2004; 92(05): 997-1002
DOI: 10.1160/TH03-10-0665
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Compensated activation of coagulation in patients with abdominal aortic aneurysm: effects of heparin treatment prior to elective surgery

Maria Magdalena Jelenska
1   Department of General, Vascular and Transplant Surgery, Medical University of Warsaw, Poland
,
Jacek Szmidt
1   Department of General, Vascular and Transplant Surgery, Medical University of Warsaw, Poland
,
Krzystof Bojakowski
1   Department of General, Vascular and Transplant Surgery, Medical University of Warsaw, Poland
,
Tomasz Grzela
1   Department of General, Vascular and Transplant Surgery, Medical University of Warsaw, Poland
2   Department of Histology and Embryology, Biostructure Research Center, Medical University of Warsaw, Poland
,
Magorzata Palester-Chlebowczyk
1   Department of General, Vascular and Transplant Surgery, Medical University of Warsaw, Poland
› Author Affiliations

Financial support: This work was supported by grant from Medical University of Warsaw (1W9/W1).
Further Information

Publication History

Received 31 October 2003

Accepted after revision 21 June 2004

Publication Date:
04 December 2017 (online)

Preview

Summary

Elective surgery of abdominal aortic aneurysm (AAA) sometimes leads to excessive bleeding and disseminated intravascular coagulation (DIC), even in patients with normal preoperative coagulation parameters. Coagulation screen, performed routinely before surgery is of limited value in the assessment of compensated activation of the haemostatic system. In this study, we used a number of additional tests (D-dimer, prothrombin fragment 1+2, antithrombin, and activation of fibrinolysis in the platelet poor plasma) for the diagnosis of compensated activation of the haemostatic system in AAA-patients. Ddimer and marker of thrombin generation (prothrombin fragment 1+2) positively correlated with each other (r = 0.768, P < 0.001). Out of 71 AAA patients, 15 patients had normal global coagulation times, but those with a Ddimer concentration above 3000 ng/ml were selected for preoperative low molecular weight heparin (LMWH) treatment. Administration of LMWH diminished coagulation abnormalities (D-dimer and prothrombin fragment 1+2 decreased significantly) and resulted in the increase of platelet number and fibrinogen concentration, indicating their previous consumption. Despite differences in aneurysm diameters between the groups of 15 LMWH treated patients (mean 70.9 ± 16 mm) and the reference group of 20 untreated AAA patients (mean 52.3 ± 8.0 mm), intraoperative parameters (operation time, blood loss and transfusion demands) were similar.